Institutional news

Three of IBEC’s women researchers have been successful in BIST’s recent ‘To the Mothers of Science’ call.

Postdocs Silvia Pujals from Nanoscopy for Nanomedicine and Marija Vukovanovic from Bacterial Infections: Antimicrobial Therapies each won a grant and coaching sessions, and senior researcher Marina Giannotti from Nanoprobes and Nanoswitches won coaching sessions.

‘To the Mothers of Science’ is a new initiative from the Barcelona Institute of Science and Technology (BIST) that aims to support women scientists who have the ambition and potential to reach a leading position in research while fulfilling maternity responsibilities at the same time. This first call bestowed 12 grants distributed among the seven BIST centres, plus coaching alone for seven finalists.

Nearly fifty undergraduate and master students attended today’s reSearch4Talent at IBEC, the fourth time we’ve opened our doors to young scholars interested in a career in science.

Held in the Dolors Aleu room of the Barcelona Science Park, the event started with a welcome and presentation about the institute from IBEC’s director, Josep Samitier, followed by specific information about applications and admissions from Ciara Boter of the HR department.

Biomaterials for Regenerative Therapies PhD student Jesús Ordoño will spend six months at Michigan State University with a Daniel Bravo scholarship.

He’s one of just three winners in the 2018 call by the Fundació Privada Daniel Bravo Andreu, which aims to to stimulate high impact biomedical research in Catalonia by awarding a monthly stipend plus travel expenses for researcher to stay in some of the most prestigious centers in the world.

Jesús will work at Michigan State University’s Institute for Quantitative Health Science and Engineering on a project entitled “Elucidation of the mechanisms and signaling pathways of lactate on cardiac regeneration”.

To round off its first Faster Future fundraising campaign, IBEC is organizing an exclusive European film première of “I’ll Push You”, the inspiring story of Justin Skeesuck and Patrick Gray, the first people to complete the Camino de Santiago in a wheelchair.

Over the past 20 years, a progressive neuromuscular disease has slowly taken away Justin’s ability to use his arms and legs. He requires daily assistance in every aspect of life such as eating, bathing and getting dressed. In the spring of 2012, Justin asked his best friend Patrick if he would help him complete the Camino de Santiago, the 500-mile pilgrimage trail in Northern Spain. Patrick’s response was simple and direct: “I’ll push you.”

Representatives from IBEC were in Boston, Massachusetts last week taking part in a business mission to accelerate the application of 3D printing to health.

Alongside companies Avinent, Diopma, Mastertec, Neos Surgery, Servocad Microtronics, Tractivus and Ventura Medical, as well as the Althaia Foundation, Fira de Barcelona and Hospital Clínic, Head of Tech Transfer Xavier Rubies—accompanied by Scientific Coordinator Mateu Pla—visited hospitals, technology centers and local laboratories and meet with investors and companies in the region to find financing, new partners or customers.

IBEC is the recipient of one of twelve MIT-Spain ”la Caixa” Foundation Seed Fund grants under a brand new funding programme in collaboration with the Massachusetts Institute of Technology.

The media presentation of the grants at Palau Macaya took place this morning, when IBEC Director Josep Samitier took part in a press conference. During the presentation Angel Font, Corporate Director of Research and Strategy at the ”la Caixa” Banking Foundation, remarked particularly on IBEC’s strong capacity for gaining competitive funding.

The ”la Caixa” and MIT grants will aim to support research projects carried out jointly between Spanish universities and research groups and MIT research groups, boosting cooperation between faculty, researchers and students. The inititative is part of the MISTI Global Seed Funds programme, which promotes collaborations between MIT faculty and researchers and their counterparts abroad.

The Executive Council of the Sociedad de Biofísica de España has awarded the 2018 Enrique Pérez-Payá SBE-40 prize to Pere Roca-Cusachs, IBEC group leader and associate professor at the UB, for his outstanding contributions to uncovering the physical basis of cellular responses to mechanical signals.

The prize has been awarded every year since 2010 and is in memory of Dr. Enrique Pérez-Payá, who contributed to the development, translation and internationalization of biophysics in Spain.

Pere will deliver a talk and receive his award at the 6th Iberian / 10th Iberoamerican Biophysics Congress in Castellón on 20th-22nd June.

Two projects coordinated by IBEC group leaders have been successful in gaining funding through the Barcelona Institute of Science and Technology’s IGNITE call, which promotes the initiation of new collaborations among BIST researchers and accelerate multidisciplinary research.

The projects were two of just five that were selected in the 2017 call to be funded through IGNITE’s seed phase. The researchers will have eight months to develop them, after which, in a second phase, an additional award for a further 12 months is given to the two best projects from the five selected during the seed phase.

Observing photosynthesis is at the heart of the Quantum-controlled Single Protein Electron Transport (Q-SPET) project, coordinated by IBEC Group Leader and ICREA research professor Pau Gorostiza and Niek van Hulst at ICFO, which aims to measure quantum effects in photosynthetic protein complexes.

An IBEC group has been awarded EU funding to coordinate a project that aims to train through research a new generation of researchers in bio-orthogonal catalysis for cancer therapy. Thanks to the Marie Curie ITN funding, the twelve consortium members of the THERACAT European Training Network – located in Spain, The Netherlands, Switzerland, UK and Israel – will be able to provide researchers with state-of-the-art multidisciplinary scientific training in the field of bio-orthogonal catalysis.